Abstract

Long non-coding RNAs (lncRNAs) are a critical class of regulatory molecules involved in a variety of biological functions; however, their role in immune cells response to radiation is unknown. Therefore, in this study we used integrative analysis to determine the expression profile of lncRNAs in mouse thymocytes and the potential functions of lncRNAs in response to radiation. Microarray data profiling indicated that 53 lncRNAs (36 up-regulated and 17 down-regulated) and 74 coding genes (39 up-regulated and 35 down-regulated) were highly differentially expressed in the high dose radiation (HDR) group compared with the control group. In the low dose radiation (LDR) group, only one lncRNA was down-regulated. Moreover, as compared with the control group, 109 lncRNA pathways in the HDR group and 14 lncRNA pathways in the LDR group were differentially expressed. Our data revealed the expression pattern of lncRNAs in mouse thymocytes and predicted their potential functions in response to LDR and HDR. In the HDR group, GO analysis showed that the role of lncRNAs in damage responses of thymocytes to HDR mainly involved chromatin organization and cell death. These findings might improve our understanding of the role of lncRNAs in LDR- and HDR-induced immune cells and provide a new experimental basis for further investigation.

Introduction

The human body is constantly exposed to various sources of radiation, including occupational exposure, environmental exposure, and exposure during medical diagnostic or therapeutic procedures. Medical procedures, especially medical imaging, are the most significant man-made sources of radiation exposure to the general population [1]. Important advances in medical imaging coupled with extraordinary growth in its utilization have been achieved in recent years [2]. The immune system is equipped with an arsenal of strategies to combat infectious threats and maintain normal health. It is well known that the immune system responds to ionizing radiation (IR) with distinct characteristics depending on the dosage and dose rate. Medium dose of IR reduces immune function and it is a fundamental cause of radiation carcinogenesis. Low dose radiation (LDR) may enhance immune function and it is an important part of the stimulatory effect of radiation. Thus, the stimulatory effect of LDR as shown in recent years has even greater significance in understanding the health effects of environmental low-level radiation and has received considerable attention in the radiation medical field [35]. As such, a more comprehensive understanding of the immune system cellular and molecular responses to IR is needed to avoid adverse radiation effects on human health.

It is known that alterations in gene expression are significant components in the response to IR. Therefore, with the advancement in high-throughput genomic technologies, global gene (mRNA) expression profiling is an effective approach to obtain information regarding the global cellular response to radiation [6,7]. Recently, long non-coding RNAs (lncRNAs) have emerged as important regulators of gene expression in diverse biological contexts. LncRNAs control gene expression in the nucleus by modulating transcription or via post-transcriptional mechanisms targeting the splicing, stability or translation of mRNAs. Our knowledge of lncRNAs’ biogenesis, their cell-type specific expressions, and their versatile molecular functions are rapidly progressing in all areas of biology [812].

In the immune cells, lncRNAs promote the distribution of Tregs in peripheral blood T cells, which causes an enhanced cell proliferation of gastric cancer cells by recruiting TGF-β and activating the TGF-β signal pathway [13]. Here we discuss these exciting new regulators and highlight an emerging paradigm of lncRNA-mediated control of gene expression in the mouse thymocytes in response to LDR and high dose radiation (HDR). In this study, the differential expression of lncRNAs and mRNAs in mouse thymocytes was determined upon exposure to different doses of X-ray whole-body irradiation (WBI), for the purpose of exploring the potential roles of lncRNAs in the regulation of coding gene expression for cellular response and biological pathways after LDR or HDR leading to thymocyte damage. Our results highlight the functions of lncRNAs in response to radiation-induced immune cell response mechanisms.

Materials and Methods

Mice and irradiation

A total of 48 ICR mice (8 weeks old, 24 male and 24 female, weighing 18–22 g) were purchased from the Experimental Animal Center of Jilin University (Changchun, China). The mice were maintained in a 12:12 light/dark cycle at a room temperature of 22 ± 1°C with free access to food and water. The male and female ICR mice were randomly divided into three groups, including control group (sham irradiation), LDR group (WBI with X-rays at a single dose of 0.075 Gy), and HDR group (WBI with X-rays at a single dose of 4.0 Gy).

An X-ray generator (Model X-RAD320iX; Precision X-ray, Inc., North Branford, USA) was used to deliver radiation at a dose rate of 0.0134 Gy/min (170 kV; 2 mA) in the LDR group and 1.020 Gy/min (180 kV; 20 mA) in the HDR group. Thymic tissues were harvested 12 h after treatment for the subsequent experiments. These experiments were approved by the Animal Experiment Ethics Committee of Jilin University [Permission Number: SCXK(J)2013-0001].

RNA labeling and array hybridization

Sample labeling and array hybridization were performed according to the manufacturer's protocols. Briefly, total RNA was extracted from each sample using TRIzol reagent (Invitrogen, Carlsbad, USA) following the manufacturer's protocol. RNA quantity and quality were measured with a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, Inc., Wilmington, USA). RNA integrity was evaluated by standard denaturing agarose gel electrophoresis. LncRNAs/mRNAs were purified from total RNA after removal of rRNA by using the Arraystar rRNA Removal Kit (Arraystar, Rockville, USA). Then, each sample was amplified and transcribed into fluorescent cRNA along the entire length of the transcripts without 3′ bias utilizing a random priming method with the Arraystar Flash RNA Labeling Kit (Arraystar). The labeled cRNAs were purified by RNeasy Mini Kit (Qiagen, Valencia, California, USA). The concentration and specific activity of the labeled cRNAs (pmol Cy3/μg cRNA) were measured with the NanoDrop ND-1000 spectrophotometer. The labeled cRNAs were hybridized onto the LncPathTM Mouse Epigenetic Pathway Array (8 × 15 K; Arraystar) according to the manufacturer's protocol. The slides were then washed and the arrays were scanned using the Agilent Scanner G2505C (Agilent Technologies, Santa Clara, USA).

Expression profiling data and analysis

Quantile normalization of raw data and subsequent data processing were performed using the R limma software package. After quantile normalization of the raw data, low-intensity filtering was performed, and the lncRNAs/coding genes that at least three out of nine samples had flags in ‘P’ or ‘M’ (All Targets Value) were retained for further analyses. All the lncRNAs were annotated with the corresponding target genes and potential regulatory mechanisms. The gene- and transcript-level expression data of the target genes were also provided to determine the expressional relationships between lncRNAs and their potential target genes.

When comparing two groups of profile differences (such as disease versus control), the ‘fold change’ (i.e. the ratio of the group averages) between the groups for each lncRNA or coding gene was computed. The statistical significance of the difference was estimated using the Student's t-test. LncRNAs or coding genes with fold change ≥2 and P < 0.05 were considered significantly differentially expressed.

Predicted regulation of lncRNAs and coding genes

LncPath™ arrays profile lncRNAs and their target genes simultaneously in a pathway-focused or disease-specific manner. By quantifying lncRNAs (at the transcript level) and their potential target genes (at both the gene and transcript level) in parallel, LncPath™ arrays provide comprehensive insights into the expressional relationship between lncRNAs and their target genes, which is helpful for establishing rapid connections between the lncRNA regulatory mechanisms and their biological functions.

Three types of lncRNAs are included in LncPath™ arrays. (i) The lncRNAs that overlap in part with critical pathway genes or locate within 3 kb from the nearest pathway genes were defined as ‘neighboring lncRNAs’, which might exert their functional roles by regulating the neighboring pathway genes at the transcriptional or post-transcriptional level. (ii) The lncRNAs with a significant possibility of functioning as competing endogenous RNAs of the critical pathway genes were defined as ‘ceRNAs’, which share miRNA response elements with the mRNA transcripts of the corresponding target genes and may prevent these mRNAs from being degraded as post-transcriptional gene regulators. (iii) The lncRNAs that locate within 300 kb of the pathway genes and may have functional properties of enhancers were defined as ‘enhancer-like lncRNAs’, which might positively regulate the expression of the distal pathway genes at the transcriptional level.

Quantitative real-time PCR

Total RNA from the same samples as those used in the microarray was extracted using the TRIzol reagent and then reverse transcribed using the PrimeScript RT reagent Kit with gDNA Eraser (Perfect Real Time; TaKaRa, Dalian, China) according to the manufacturer's recommendations. The quantitative real-time PCR (qRT-PCR) was performed using SYBR Green assay (TaKaRa), and the mouse housekeeping ’GAPDH’ was used as an internal control. The primers for each lncRNA were designed according to Primer 3 (http://sourceforge.net/projects/primer3/) online and checked with Basic Local Alignment Search Tool (BLAST) of National Center of Biotechnology Information (NCBI) to ensure unique amplification product as listed in Table 1. PCR was performed in a total reaction volume of 25 μl, including 12.5 μl of SYBR Premix Ex Taq (2×), 1 μl of PCR Forward Primer (10 μM), 1 μl of PCR Reverse Primer (10 μM), 2 μl of cDNA, and 8.5 μl of double-distilled water. The cycling conditions consisted of an initial single cycle of 30 s at 95°C, and followed by 40 cycles of 5 s at 95°C and 30 s at 60°C. All reactions were run in triplicate. The relative expression of genes was calculated based on the 2−ΔΔCt method.

Gene Ontology and coding–non-coding gene co-expression network

The Gene Ontology (GO) project provides a controlled vocabulary to describe gene and gene product attributes in any organism (http://www.geneontology.org). The ontology covers three domains: Biological Process, Cellular Component, and Molecular Function. Fisher's exact test is used to determine if there is more overlap between the differentially expressed (DE) list and the GO annotation list than that would be expected by chance. The P-value denotes the significance of GO term enrichment in the DE genes. The lower the P-value, the more significant the GO term (P < 0.05 is recommended). A coding–non-coding gene co-expression network (CNC network) was constructed with three pairs of the most significantly changed lncRNAs and their target genes in the HDR group, which were presented to identify interactions among genes. The method was performed according to Liao [14] and performed by KangChen Bio-tech (Shanghai, China).

Statistical analysis

The results were presented as the mean ± SD. Statistical comparisons of the experimental results between the treated and control groups were evaluated using the Student's t-test. All statistical tests were performed with SPSS version 22.0 (SPSS, Inc., Chicago, USA). P < 0.05 was considered as statistically significant difference.

Results

Profile of microarray data

For the microarray analysis, 499 lncRNAs (Fig. 1A,B) and 649 coding transcripts (Fig. 1C,D) were detected. They were carefully collected from the most authoritative databases such as RefSeq, UCSC Knowngenes, Ensembl, and many related reports. Scatter-Plot, a visualization method, was used to assess gene expression variation between the two groups and hierarchical clustering showed the gene expression patterns of the samples. Volcano plots are useful tools for visualizing differential expression between two different conditions. They are constructed using fold-change values and P-values, and thus allow visualization of the relationship between the magnitude of change and statistical significance. Of all the lncRNAs, 36 were up-regulated (fold change ≥2 and P < 0.05) and 17 were down-regulated (fold change ≥2 and P < 0.05) in the HDR group compared with the control group (Fig. 2A–C). Of all the mRNAs, 39 were up-regulated (fold change ≥2 and P < 0.05) and 35 were down-regulated (fold change ≥2 and P < 0.05) in the HDR group compared with the control group (Fig. 3A–C). Compared with the control group, these expression differences were not found in the LDR group, with the exception only one lncRNA which was down-regulated (fold change ≥2 and P < 0.05) (Table 2).
Profile of microarray data (A,B) Differentially expressed lncRNAs (A) and differentially expressed mRNAs (B) were analyzed using hierarchical clustering. Hierarchical clustering analysis arranges samples into groups based on their expression level, which allows us to hypothesize the relationships between samples. ‘Red’ indicates high relative expression, and ‘green’ indicates low relative expression. (C,D) Box plot of lncRNA (C) and mRNA (D). They were used to observe and compare the distributions of gene expression values in the samples after normalization.
Figure 1.

Profile of microarray data (A,B) Differentially expressed lncRNAs (A) and differentially expressed mRNAs (B) were analyzed using hierarchical clustering. Hierarchical clustering analysis arranges samples into groups based on their expression level, which allows us to hypothesize the relationships between samples. ‘Red’ indicates high relative expression, and ‘green’ indicates low relative expression. (C,D) Box plot of lncRNA (C) and mRNA (D). They were used to observe and compare the distributions of gene expression values in the samples after normalization.

LncRNA profile of the HDR group microarray data (A) Hierarchical Clustering shows a distinguishable lncRNA expression profile between the two groups and homogeneity within each group. (B) Volcano Plot of the differentially expressed lncRNAs. The red points in the plot represent the differentially expressed lncRNAs with statistical significance. (C) Scatter-Plot of lncRNA expression. The lncRNAs above the top green line and below the bottom green line indicated a more than 2.0-fold change in lncRNAs between the HDR group and control samples.
Figure 2.

LncRNA profile of the HDR group microarray data (A) Hierarchical Clustering shows a distinguishable lncRNA expression profile between the two groups and homogeneity within each group. (B) Volcano Plot of the differentially expressed lncRNAs. The red points in the plot represent the differentially expressed lncRNAs with statistical significance. (C) Scatter-Plot of lncRNA expression. The lncRNAs above the top green line and below the bottom green line indicated a more than 2.0-fold change in lncRNAs between the HDR group and control samples.

mRNA profile of HDR group microarray data (A) Hierarchical Clustering shows a distinguishable mRNA expression profile between the two groups and homogeneity within each group. (B) Volcano Plot of the differentially expressed mRNAs. The red points in the plot represent the differentially expressed mRNAs with statistical significance. (C) Scatter-Plot of mRNA expression. The mRNAs above the top green line and below the bottom green line indicated a more than 2.0-fold change in mRNAs between the HDR group and control samples.
Figure 3.

mRNA profile of HDR group microarray data (A) Hierarchical Clustering shows a distinguishable mRNA expression profile between the two groups and homogeneity within each group. (B) Volcano Plot of the differentially expressed mRNAs. The red points in the plot represent the differentially expressed mRNAs with statistical significance. (C) Scatter-Plot of mRNA expression. The mRNAs above the top green line and below the bottom green line indicated a more than 2.0-fold change in mRNAs between the HDR group and control samples.

Table 2.

The pathways in the LDR group

Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipSymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000058706Gm78160.01452.1366Downchr5EnhancerUpstreamHs3st10.02261.3030Upchr5
AK0472820.00111.4372Upchr5EnhancerDownstreamHs3st10.02261.3030Upchr5
AK0831620.03211.3419Upchr18NeighboringUpstreamMbd20.01991.3159Downchr18
ENSMUST00000058881Gm53410.00051.3116Downchr7EnhancerDownstreamEed0.00991.4367Downchr7
Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipSymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000058706Gm78160.01452.1366Downchr5EnhancerUpstreamHs3st10.02261.3030Upchr5
AK0472820.00111.4372Upchr5EnhancerDownstreamHs3st10.02261.3030Upchr5
AK0831620.03211.3419Upchr18NeighboringUpstreamMbd20.01991.3159Downchr18
ENSMUST00000058881Gm53410.00051.3116Downchr7EnhancerDownstreamEed0.00991.4367Downchr7
Table 2.

The pathways in the LDR group

Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipSymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000058706Gm78160.01452.1366Downchr5EnhancerUpstreamHs3st10.02261.3030Upchr5
AK0472820.00111.4372Upchr5EnhancerDownstreamHs3st10.02261.3030Upchr5
AK0831620.03211.3419Upchr18NeighboringUpstreamMbd20.01991.3159Downchr18
ENSMUST00000058881Gm53410.00051.3116Downchr7EnhancerDownstreamEed0.00991.4367Downchr7
Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipSymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000058706Gm78160.01452.1366Downchr5EnhancerUpstreamHs3st10.02261.3030Upchr5
AK0472820.00111.4372Upchr5EnhancerDownstreamHs3st10.02261.3030Upchr5
AK0831620.03211.3419Upchr18NeighboringUpstreamMbd20.01991.3159Downchr18
ENSMUST00000058881Gm53410.00051.3116Downchr7EnhancerDownstreamEed0.00991.4367Downchr7

LncRNA target prediction

LncPathTM arrays profile lncRNAs and their target genes simultaneously in a pathway-focused or disease-specific manner by quantifying lncRNAs (at the transcript level) and their potential target genes (at both the gene and transcript level) in parallel. In terms of the regulated target genes, up to 681 lncRNAs were co-expressed with target coding genes in the sample. The LDR group had four pathways that contained the predicted target genes (fold change >1.3, P < 0.05), while the HDR group had 17 pathways that were changed significantly (fold change ≥1.5 and P < 0.05) (Tables 2 and 3).

Table 3.

The pathways in the HDR group

Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipBinding miRNASymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000141797Gm161940.00687.5347Upchr17EnhancerUpstreamCdkn1a0.00007.8613Upchr17
AK0432710.00032.6043Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
AK0213900.00072.4458Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
ENSMUST00000121087Gm73080.00182.1328Downchr6EnhancerDownstreamCcnd20.00003.0458Upchr6
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-106a-5p, mmu-miR-106b-5p, mmu-miR-20a-5p, mmu-miR-98-3p, mmu-miR-17-5p, mmu-miR-467a-3p, mmu-miR-546, mmu-miR-669b-3p, mmu-miR-669f-3pAsf1a0.00032.9712Downchr10
AA0890930.00025.2867Upchr6EnhancerUpstreamEzh20.00082.6988Downchr6
ENSMUST00000118617Gm125130.00103.2815Downchr4EnhancerUpstreamKlf40.00192.1494Upchr4
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-29b-3p, mmu-let-7a-1-3p, mmu-let-7b-3p, mmu-let-7c-2-3p, mmu-let-7f-1-3p, mmu-miR-29a-3p, mmu-miR-29c-3p, mmu-miR-98-3p, mmu-miR-467a-3p, mmu-miR-770-5p, mmu-miR-669b-3p, mmu-miR-669f-3pHat10.00092.1308Downchr2
AK1465320.01122.0950Upchr16EnhancerDownstreamBcl60.00201.9466Downchr16
ENSMUST00000120026Gm135880.01122.0131Upchr2EnhancerDownstreamNek60.00511.9079Upchr2
ENSMUST00000181355Gm265880.00703.1890Upchr6EnhancerUpstreamMgll0.01581.8993Upchr6
AK0070400.00402.2962Upchr10EnhancerUpstreamNuak10.00521.8268Upchr10
AK0826340.01482.4210Upchr8EnhancerUpstreamCdh110.00091.7708Upchr8
uc007xjz.12610037D02Rik0.00262.0648Upchr15EnhancerUpstreamArid20.00031.6935Downchr15
NR_0453184930552P12Rik0.010816.8170Upchr19ceRNAmmu-miR-27b-3p, mmu-let-7a-2-3p, mmu-miR-18a-3p, mmu-miR-22-3p, mmu-miR-671-5p, mmu-miR-666-3p, mmu-miR-873a-5p, mmu-miR-3096b-5p, mmu-miR-6370Arid20.00281.5827Downchr15
NR_045162A330048O09Rik0.00832.3592Upchr13EnhancerDownstreamId40.00631.5671Upchr13
AK0472820.00365.1151Upchr5EnhancerDownstreamHs3st10.00371.5441Upchr5
Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipBinding miRNASymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000141797Gm161940.00687.5347Upchr17EnhancerUpstreamCdkn1a0.00007.8613Upchr17
AK0432710.00032.6043Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
AK0213900.00072.4458Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
ENSMUST00000121087Gm73080.00182.1328Downchr6EnhancerDownstreamCcnd20.00003.0458Upchr6
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-106a-5p, mmu-miR-106b-5p, mmu-miR-20a-5p, mmu-miR-98-3p, mmu-miR-17-5p, mmu-miR-467a-3p, mmu-miR-546, mmu-miR-669b-3p, mmu-miR-669f-3pAsf1a0.00032.9712Downchr10
AA0890930.00025.2867Upchr6EnhancerUpstreamEzh20.00082.6988Downchr6
ENSMUST00000118617Gm125130.00103.2815Downchr4EnhancerUpstreamKlf40.00192.1494Upchr4
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-29b-3p, mmu-let-7a-1-3p, mmu-let-7b-3p, mmu-let-7c-2-3p, mmu-let-7f-1-3p, mmu-miR-29a-3p, mmu-miR-29c-3p, mmu-miR-98-3p, mmu-miR-467a-3p, mmu-miR-770-5p, mmu-miR-669b-3p, mmu-miR-669f-3pHat10.00092.1308Downchr2
AK1465320.01122.0950Upchr16EnhancerDownstreamBcl60.00201.9466Downchr16
ENSMUST00000120026Gm135880.01122.0131Upchr2EnhancerDownstreamNek60.00511.9079Upchr2
ENSMUST00000181355Gm265880.00703.1890Upchr6EnhancerUpstreamMgll0.01581.8993Upchr6
AK0070400.00402.2962Upchr10EnhancerUpstreamNuak10.00521.8268Upchr10
AK0826340.01482.4210Upchr8EnhancerUpstreamCdh110.00091.7708Upchr8
uc007xjz.12610037D02Rik0.00262.0648Upchr15EnhancerUpstreamArid20.00031.6935Downchr15
NR_0453184930552P12Rik0.010816.8170Upchr19ceRNAmmu-miR-27b-3p, mmu-let-7a-2-3p, mmu-miR-18a-3p, mmu-miR-22-3p, mmu-miR-671-5p, mmu-miR-666-3p, mmu-miR-873a-5p, mmu-miR-3096b-5p, mmu-miR-6370Arid20.00281.5827Downchr15
NR_045162A330048O09Rik0.00832.3592Upchr13EnhancerDownstreamId40.00631.5671Upchr13
AK0472820.00365.1151Upchr5EnhancerDownstreamHs3st10.00371.5441Upchr5
Table 3.

The pathways in the HDR group

Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipBinding miRNASymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000141797Gm161940.00687.5347Upchr17EnhancerUpstreamCdkn1a0.00007.8613Upchr17
AK0432710.00032.6043Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
AK0213900.00072.4458Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
ENSMUST00000121087Gm73080.00182.1328Downchr6EnhancerDownstreamCcnd20.00003.0458Upchr6
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-106a-5p, mmu-miR-106b-5p, mmu-miR-20a-5p, mmu-miR-98-3p, mmu-miR-17-5p, mmu-miR-467a-3p, mmu-miR-546, mmu-miR-669b-3p, mmu-miR-669f-3pAsf1a0.00032.9712Downchr10
AA0890930.00025.2867Upchr6EnhancerUpstreamEzh20.00082.6988Downchr6
ENSMUST00000118617Gm125130.00103.2815Downchr4EnhancerUpstreamKlf40.00192.1494Upchr4
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-29b-3p, mmu-let-7a-1-3p, mmu-let-7b-3p, mmu-let-7c-2-3p, mmu-let-7f-1-3p, mmu-miR-29a-3p, mmu-miR-29c-3p, mmu-miR-98-3p, mmu-miR-467a-3p, mmu-miR-770-5p, mmu-miR-669b-3p, mmu-miR-669f-3pHat10.00092.1308Downchr2
AK1465320.01122.0950Upchr16EnhancerDownstreamBcl60.00201.9466Downchr16
ENSMUST00000120026Gm135880.01122.0131Upchr2EnhancerDownstreamNek60.00511.9079Upchr2
ENSMUST00000181355Gm265880.00703.1890Upchr6EnhancerUpstreamMgll0.01581.8993Upchr6
AK0070400.00402.2962Upchr10EnhancerUpstreamNuak10.00521.8268Upchr10
AK0826340.01482.4210Upchr8EnhancerUpstreamCdh110.00091.7708Upchr8
uc007xjz.12610037D02Rik0.00262.0648Upchr15EnhancerUpstreamArid20.00031.6935Downchr15
NR_0453184930552P12Rik0.010816.8170Upchr19ceRNAmmu-miR-27b-3p, mmu-let-7a-2-3p, mmu-miR-18a-3p, mmu-miR-22-3p, mmu-miR-671-5p, mmu-miR-666-3p, mmu-miR-873a-5p, mmu-miR-3096b-5p, mmu-miR-6370Arid20.00281.5827Downchr15
NR_045162A330048O09Rik0.00832.3592Upchr13EnhancerDownstreamId40.00631.5671Upchr13
AK0472820.00365.1151Upchr5EnhancerDownstreamHs3st10.00371.5441Upchr5
Seq nameGene symbolP-valueFold changeRegulationCo-ordinatesPotential mechanismGenomic relationshipBinding miRNASymbolP-valueFold changeRegulationCo-ordinates
ENSMUST00000141797Gm161940.00687.5347Upchr17EnhancerUpstreamCdkn1a0.00007.8613Upchr17
AK0432710.00032.6043Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
AK0213900.00072.4458Downchr19EnhancerUpstreamHells0.00014.0311Downchr19
ENSMUST00000121087Gm73080.00182.1328Downchr6EnhancerDownstreamCcnd20.00003.0458Upchr6
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-106a-5p, mmu-miR-106b-5p, mmu-miR-20a-5p, mmu-miR-98-3p, mmu-miR-17-5p, mmu-miR-467a-3p, mmu-miR-546, mmu-miR-669b-3p, mmu-miR-669f-3pAsf1a0.00032.9712Downchr10
AA0890930.00025.2867Upchr6EnhancerUpstreamEzh20.00082.6988Downchr6
ENSMUST00000118617Gm125130.00103.2815Downchr4EnhancerUpstreamKlf40.00192.1494Upchr4
uc008ref.2F30.000218.9992Upchr3ceRNAmmu-miR-29b-3p, mmu-let-7a-1-3p, mmu-let-7b-3p, mmu-let-7c-2-3p, mmu-let-7f-1-3p, mmu-miR-29a-3p, mmu-miR-29c-3p, mmu-miR-98-3p, mmu-miR-467a-3p, mmu-miR-770-5p, mmu-miR-669b-3p, mmu-miR-669f-3pHat10.00092.1308Downchr2
AK1465320.01122.0950Upchr16EnhancerDownstreamBcl60.00201.9466Downchr16
ENSMUST00000120026Gm135880.01122.0131Upchr2EnhancerDownstreamNek60.00511.9079Upchr2
ENSMUST00000181355Gm265880.00703.1890Upchr6EnhancerUpstreamMgll0.01581.8993Upchr6
AK0070400.00402.2962Upchr10EnhancerUpstreamNuak10.00521.8268Upchr10
AK0826340.01482.4210Upchr8EnhancerUpstreamCdh110.00091.7708Upchr8
uc007xjz.12610037D02Rik0.00262.0648Upchr15EnhancerUpstreamArid20.00031.6935Downchr15
NR_0453184930552P12Rik0.010816.8170Upchr19ceRNAmmu-miR-27b-3p, mmu-let-7a-2-3p, mmu-miR-18a-3p, mmu-miR-22-3p, mmu-miR-671-5p, mmu-miR-666-3p, mmu-miR-873a-5p, mmu-miR-3096b-5p, mmu-miR-6370Arid20.00281.5827Downchr15
NR_045162A330048O09Rik0.00832.3592Upchr13EnhancerDownstreamId40.00631.5671Upchr13
AK0472820.00365.1151Upchr5EnhancerDownstreamHs3st10.00371.5441Upchr5

These co-expressed coding genes were identified as target genes regulated by differentially expressed lncRNAs. For instance, in the HDR group the down-regulated coding genes Asf1a (fold change: 2.97) were predicted to be the target genes regulated by the up-regulated lncRNA uc008ref.2 (fold change: 18.999), which has ‘ceRNA’-shared miRNA response elements (including mmu-miR-106a-5p, mmu-miR-106b-5p, and mmu-miR-20a-5p) with their corresponding target genes, and may prevent Asf1a from being degraded as a post-transcriptional gene regulator.

qRT-PCR validation

According to the lncRNA target prediction of lncRNA/mRNA expression profiling, and to confirm the reliability of our microarray data, we randomly selected two pathways (lncRNAs: ENSMUST00000058706, AK083162, and their target coding genes: Hs3st1, Mbd2) from the LDR group (fold change >1.3) and three pathways (lncRNAs: AA089093, AK043271, and uc008ref.2; and their target coding genes: Ezh2, Hells, and Asf1a) from the HDR group (fold change ≥2). These lncRNAs were selected based upon their regulation directions and significance. The expression levels in nine samples were analyzed by qRT-PCR. The qRT-PCR results were consistent with the microarray data and showed the same trends in up- or down-regulation for each gene (Fig. 4A–D). The primers designed by Sangon Biotech (Shanghai, China) are shown in Table 1.
The expression profiles of the selected lncRNAs and their co-expressed mRNAs in the two groups (A,B) The heatmap of selected lncRNAs and their co-expressed mRNAs in the HDR group and LDR group. (C, D) The expression patterns of the genes as monitored by qRT-PCR.
Figure 4.

The expression profiles of the selected lncRNAs and their co-expressed mRNAs in the two groups (A,B) The heatmap of selected lncRNAs and their co-expressed mRNAs in the HDR group and LDR group. (C, D) The expression patterns of the genes as monitored by qRT-PCR.

Table 1.

Sequence of primers for qRT-PCR

GeneForward primer (5′→3′)Reverse primer (5′→3′)
GAPDHCGGAGTCAACGGATTTGGTCGTATAGCCTTCTCCATGGTGGTGAAGAC
AA089093GCCTCCTTCAGCAAATCCTAGTGTGGGCAGTGTTCAGGTA
AK043271GGTAGAGGCTACAGTGAGCGTGTTTTAGGCTGGGATGACG
uc008ref.2CAACCCAAACCCACCAACTACCAGGTCACATCCTTCACG
ENSMUST00000058706TGTTCTTTGGAGGAGGAGGAATTCTTTTGCCGAGCCAGT
AK083162GAACCCTGCTGTTTGGCTTAGCACAGCGGAGGAATTTCAA
Ezh2CGGGACTAGGGAGTGTTCAGGTTGTAAGGGCGACCAAGAG
HellsCTTCCTAACTGGATGGCTGAATGTCCCTTGTCTTTTGTGGA
Asf1aAAGGGAAAACCCACCAGTAAACTTTGACGCTGACGGTAATG
Hs3st1TCTTTGACTGGGAGGAGCATTGAAATAGGCGGGTGTCTTC
Mbd2CATTCACAGGGGGAGATACGGTGCCTCCTCCAGTTTCTTG
GeneForward primer (5′→3′)Reverse primer (5′→3′)
GAPDHCGGAGTCAACGGATTTGGTCGTATAGCCTTCTCCATGGTGGTGAAGAC
AA089093GCCTCCTTCAGCAAATCCTAGTGTGGGCAGTGTTCAGGTA
AK043271GGTAGAGGCTACAGTGAGCGTGTTTTAGGCTGGGATGACG
uc008ref.2CAACCCAAACCCACCAACTACCAGGTCACATCCTTCACG
ENSMUST00000058706TGTTCTTTGGAGGAGGAGGAATTCTTTTGCCGAGCCAGT
AK083162GAACCCTGCTGTTTGGCTTAGCACAGCGGAGGAATTTCAA
Ezh2CGGGACTAGGGAGTGTTCAGGTTGTAAGGGCGACCAAGAG
HellsCTTCCTAACTGGATGGCTGAATGTCCCTTGTCTTTTGTGGA
Asf1aAAGGGAAAACCCACCAGTAAACTTTGACGCTGACGGTAATG
Hs3st1TCTTTGACTGGGAGGAGCATTGAAATAGGCGGGTGTCTTC
Mbd2CATTCACAGGGGGAGATACGGTGCCTCCTCCAGTTTCTTG
Table 1.

Sequence of primers for qRT-PCR

GeneForward primer (5′→3′)Reverse primer (5′→3′)
GAPDHCGGAGTCAACGGATTTGGTCGTATAGCCTTCTCCATGGTGGTGAAGAC
AA089093GCCTCCTTCAGCAAATCCTAGTGTGGGCAGTGTTCAGGTA
AK043271GGTAGAGGCTACAGTGAGCGTGTTTTAGGCTGGGATGACG
uc008ref.2CAACCCAAACCCACCAACTACCAGGTCACATCCTTCACG
ENSMUST00000058706TGTTCTTTGGAGGAGGAGGAATTCTTTTGCCGAGCCAGT
AK083162GAACCCTGCTGTTTGGCTTAGCACAGCGGAGGAATTTCAA
Ezh2CGGGACTAGGGAGTGTTCAGGTTGTAAGGGCGACCAAGAG
HellsCTTCCTAACTGGATGGCTGAATGTCCCTTGTCTTTTGTGGA
Asf1aAAGGGAAAACCCACCAGTAAACTTTGACGCTGACGGTAATG
Hs3st1TCTTTGACTGGGAGGAGCATTGAAATAGGCGGGTGTCTTC
Mbd2CATTCACAGGGGGAGATACGGTGCCTCCTCCAGTTTCTTG
GeneForward primer (5′→3′)Reverse primer (5′→3′)
GAPDHCGGAGTCAACGGATTTGGTCGTATAGCCTTCTCCATGGTGGTGAAGAC
AA089093GCCTCCTTCAGCAAATCCTAGTGTGGGCAGTGTTCAGGTA
AK043271GGTAGAGGCTACAGTGAGCGTGTTTTAGGCTGGGATGACG
uc008ref.2CAACCCAAACCCACCAACTACCAGGTCACATCCTTCACG
ENSMUST00000058706TGTTCTTTGGAGGAGGAGGAATTCTTTTGCCGAGCCAGT
AK083162GAACCCTGCTGTTTGGCTTAGCACAGCGGAGGAATTTCAA
Ezh2CGGGACTAGGGAGTGTTCAGGTTGTAAGGGCGACCAAGAG
HellsCTTCCTAACTGGATGGCTGAATGTCCCTTGTCTTTTGTGGA
Asf1aAAGGGAAAACCCACCAGTAAACTTTGACGCTGACGGTAATG
Hs3st1TCTTTGACTGGGAGGAGCATTGAAATAGGCGGGTGTCTTC
Mbd2CATTCACAGGGGGAGATACGGTGCCTCCTCCAGTTTCTTG

GO analysis

To investigate the roles of lncRNAs following radiation, GO analysis, a functional analysis which associates differentially expressed mRNAs with GO categories, was performed. The results for the HDR group were obvious, thus the GO analysis was performed to determine the gene and gene product enrichment in biological processes, cellular components, and molecular functions in mouse thymocytes. Fisher's exact test was used to determine whether there was more overlap between the DE and the GO annotation list than that would be expected by chance (P < 0.05 is recommended). The results in Fig. 5 showed that the down-regulated transcripts were related to chromatin organization (GO: biological processes), chromatin binding (GO: cellular components), and the ESC/E(Z) complex (GO: molecular functions); while the highest enriched GOs targeted by up-regulated transcripts were related to cell death (GO: biological processes), nucleus (GO: cellular components), and kinase regulator activity (GO: molecular functions).
The GO analysis (A) GO down-regulated and (B) GO up-regulated. The P-value denotes the significance of GO term enrichment in the DE genes. The lower the P-value, the more significant the GO term (P ≤ 0.05 was recommended as the cut-off value).
Figure 5.

The GO analysis (A) GO down-regulated and (B) GO up-regulated. The P-value denotes the significance of GO term enrichment in the DE genes. The lower the P-value, the more significant the GO term (P ≤ 0.05 was recommended as the cut-off value).

CNC network

In order to identify the possible modulating mechanism of lncRNAs in the HDR group, a CNC network was constructed based on the strength of the correlation between the differentially expressed mRNAs and lncRNAs (Fig. 6). LncRNAs and mRNAs with Pearson correlation coefficients that exceeded 0.995 were selected to construct the network. The three pairs of lncRNA pathways selected from the HDR group were shown in Fig. 6. Interestingly, these network pairs were all positive. Totally, 161 lncRNAs and 156 mRNAs formed the CNC network nodes and 228 network pairs were obtained. In this co-expression network, a single lncRNA may correlate with many mRNAs and vice versa. In addition, among these network pairs, there were also correlations between several top lncRNAs and top mRNAs. For instance, lncRNA ENST00000141797 (fold change: 7.5347226) and mRNA Cdkn1a (fold change: 7.861313) were predicted to co-express with a Pearson correlation coefficient of 0.997. These were one of the most significantly expressed lncRNAs and mRNAs, respectively. This selected pair pathway might be a center in this CNC network. All the targets mentioned here have been reported to be linked to chromatin binding and transcriptional regulation.
Coding–non-coding gene co-expression network The blue circular nodes represent the mRNA, the orange box nodes represent the lncRNA. The solid lines represent the correlation. The node size indicates the number associated with these genes, where nodes with more gene co-expression have a more extensive relationship with the gene.
Figure 6.

Coding–non-coding gene co-expression network The blue circular nodes represent the mRNA, the orange box nodes represent the lncRNA. The solid lines represent the correlation. The node size indicates the number associated with these genes, where nodes with more gene co-expression have a more extensive relationship with the gene.

Discussion

Recently, lncRNAs have also been recognized as important regulators with biological functions. However, the expression patterns of lncRNAs and the classification of lncRNAs subgroups in the immune cells affected by radiation have not been fully clarified. In terms of immunization, Petri [15] provided an important resource for future studies on the functions of lncRNAs in the development of adaptive immune response. Subsequent studies have revealed that lncRNAs may impact the transcriptional programs of immune cells required to fight against pathogens and maintain normal health and homeostasis [16]. These studies suggest that non-coding RNAs play important roles in the immune cells.

In terms of radiation, photon radiation (X-rays and gamma-rays) is still a predominant type of IR used in radiotherapy with low linear energy transfer radiation compared with proton and alpha particles [17]. The mechanism of cell injury induced by low linear energy transfer radiation is mainly via free radicals, which induce DNA and cell membrane damage [1820]. Various studies have confirmed that exposure to IR increases the risk of cancer [2123]. The establishment of dose–response relationship for biological parameters is one of the topics in radiobiology research. Due to the importance of immune surveillance against cancer and infection, radiation effects on the immune system are one of the chief research fields in radiation biology and radiation protection. Our results revealed that some parameters were influenced in response to HDR and LDR radiation in mouse thymocytes. These parameters include: cell activities such as cell cycle control and cell survival (apoptosis), surface molecules, and signal molecules [24]. Therefore, it is essential to clarify the role of lncRNAs in the damage of immune cells when exposed to radiation.

In this study, we used 0.075 and 4.0 Gy of X-rays in the LDR and HDR, respectively, because these doses were used in most immunological studies to evaluate the response of lymphocytes to WBI [25]. Then RNAs were extracted from the thymus for the LncPathTM microarray, and a small number of lncRNAs and their predicted target genes were selected for validation by quantitative RT-PCR. When reanalyzing the microarray data, the genes differentially expressed in the LDR group were not obvious, while those in the HDR group were obvious and therefore were analyzed further. By quantifying lncRNAs (at the transcript level) and their potential target genes (at both the gene and transcript level) in parallel, LncPathTM Pathway Focus LncRNA Microarrays provided comprehensive insights into the expressional relationship between lncRNAs and their target genes, which was helpful in establishing rapid connections between the lncRNA regulatory mechanisms and their biological functions in immune cells, which were subject to WBI.

It is well known that HDR could induce DNA damage and severe DNA damage might lead to apoptosis or cell death [2628]. In this study, GO analysis revealed that the genes biological processes involving in ‘cell death’, ‘programmed cell death’, and ‘proliferation’ were significantly enriched among the up-regulated genes in response to HDR. When reanalyzing microarray data in the HDR group, we found significant expression of coding genes, which are involved in ‘cell death’. For example, the lncRNA NR_028591 expression was elevated after HDR, which up-regulated the potential target genes BCL2L11 expression on the transcript level. The BCL2L11 is a member of the BCL-2 family and locates in the outer membrane of mitochondria, which acts as an important regulator that mediates excitotoxic apoptosis, apoptosis-inducing factor translocation and mitochondrial depolarization [29,30]. The GO analysis of down-regulated genes showed that these genes corresponded to ‘chromatin organization’ or ‘modification’, and ‘regulation of cellular macromolecule biosynthesis’ (Fig. 5B). For example, the lncRNA AA089093 expression was elevated, which down-regulated the potential target gene Ezh2 expression. Previous studies revealed that, in response to IL-1β and TGFβ2, TAGLN expression in endothelial cells is co-regulated at the chromatin level through histone methylation (H3K27me3), most likely through regulation of the abundance of the Polycomb methyltrasferase EZH2. EZH2 appears to integrate and mediate the IL-1β and TGFβ signaling at the epigenetic level [31]. Our previous research confirmed that HDR could induce the production of CD4+CD25+Nrp1+ cells, which inhibited immune responses in general through the release of TGF-β1 and IL-10. This process may be related to the PLC-PIP2 and cAMP-PKA signal pathways [32]. This provided an example of how cellular signaling could be resolved at the level of epigenetic regulation.

Therefore, the lncRNAs of these regulated target genes exert their biological functions at both the transcription and translation level. They regulate target genes by interacting with the transcriptional machinery or collaborating with chromatin modifiers directly. For instance, several lncRNAs, such as CCND1, gadd7, ANRIL, and PANDA, were induced by DNA damage. The expression of the lncRNA RoR, lncRNA p21, p53-induced eRNA, and loc285194 were modulated upon DNA damage in a p53-dependent manner [3336]. In order to identify the possible modulating mechanism of lncRNAs in the HDR group, we constructed the CNC network based on the Pearson correlation analysis data of 161 lncRNAs and 156 mRNAs (protein-coding), which were associated with 228 network pairs of co-expressing lncRNAs and mRNAs. Most of these pairs showed a positive correlation. In Fig. 6, it was demonstrated that the selected genes such as those in the center in several circles and a single lncRNA could be correlated with many mRNAs or lncRNAs. For example, uc008ref.2 and ENSMUST00000141797 were closely related to coding RNAs or lncRNAs and had some in common, such as the coding gene Cdkn1a (also called p21Cip1), which was previously proposed as a biomarker gene after radiation exposure. CDKN1A is a conserved protein belonging to the CDK inhibitor Cip/Kip family, and has been implicated in the regulation of many cellular processes, such as proliferation, differentiation, apoptosis, metastasis, cell survival, and stem cell renewal. Expression of CDKN1A could be regulated at the transcriptional level by oncogenes and tumor suppressor proteins that bind various transcription factors to specific elements in response to a variety of intracellular and extracellular signals [37,38]. Therefore, we speculate that uc008ref.2 and ENSMUST00000141797 may respond to HDR by interacting with cellular processes through CDKN1A. Other mRNAs were also co-expressed with their corresponding lncRNAs. All the targets mentioned here have also been reported to be linked to ‘cellular mechanisms’, ‘transcriptional regulation’, and ‘chromatin binding’, consistent with the GO analysis results. Thus, lncRNAs might interact with these targets. These findings suggest that lncRNAs and their target gene network may play important roles in the regulation of cellular response and biological response to IR damage. However, further studies are required to determine how these lncRNAs are involved in the transcriptional and post-transcriptional regulation of their related genes.

In summary, this study demonstrates the profile of differentially expressed lncRNAs and their co-expressed coding genes involved in the damage responses of thymocytes to LDR and HDR. It is suggested that lncRNAs may also act as co-regulators of transcription factors to regulate gene transcription in immune cells in response to IR, or to affect the expression of adjacent coding genes. Considering that only a small percentage of the total lncRNA population has been studied up to date, we are just at the beginning of this research. Further work is needed to clarify the significance of lncRNAs in response to IR damage, which may have a profound impact on our understanding of the biological and molecular mechanisms involved in IR-induced DNA damage response, and may result in novel therapeutic approaches.

Funding

This work was supported by the grants from the National Natural Science Foundation of China (Nos. 30870584, 81371890, and 81573085) and the Doctoral Program Foundation of Institutions of Higher Education of China (No. 20120061110063).

References

1

Thaker
A
,
Navadeh
S
,
Gonzales
H
,
Malekinejad
M
.
Effectiveness of policies on reducing exposure to ionizing radiation from medical imaging: a systematic review
.
J Am Coll Radiol
2015
,
12
:
1434
1445
.

2

Einstein
AJ
.
Medical imaging: the radiation issue
.
Naterv Cardiol
2009
,
6
:
436
438
.

3

Gong
SL
,
Liu
SC
,
Liu
JX
,
Zhang
YC
,
Liu
SZ
.
Adaptive response of thymocyte apoptosis and cell cycle progression induced by low dose X-ray irradiation in mice
.
Biomed Environ Sci
2000
,
13
:
180
188
.

4

Liu
SZ
,
Liu
WH
,
Sun
JB
.
Radiation hormesis: its expression in the immune system
.
Health Phys
1987
,
52
:
579
583
.

5

Jin
SZ
,
Pan
XN
,
Wu
N
,
Jin
GH
,
Liu
SZ
.
Whole-body low dose irradiation promotes the efficacy of conventional radiotherapy for cancer and possible mechanisms
.
Dose Response
2007
,
5
:
349
358
.

6

Chauhan
V
,
Howland
M
,
Wilkins
R
.
Identification of gene-based responses in human blood cells exposed to alpha particle radiation
.
BMC Med Genom
2014
,
7
:
43
.

7

Xie
L
,
Zhou
J
,
Zhang
S
,
Chen
Q
,
Lai
R
,
Ding
W
,
Song
C
, et al. .
Integrating microRNA and mRNA expression profiles in response to radiation-induced injury in rat lung
.
Radita Oncol
2014
,
9
:
111
.

8

Zhu
H
,
Ouyang
J
,
Chen
JL
.
Function and regulation of long non-coding RNAs in tumorigenesis and host innate immunity-A review
.
Wei Sheng Wu Xue Bao
2015
,
55
:
801
812
.

9

Pan
JJ
,
Xie
XJ
,
Li
X
,
Chen
W
.
Long non-coding RNAs and drug resistance
.
Asiam Pac J Cancer Prev
2015
,
16
:
8067
8073
.

10

Kornienko
AE
,
Dotter
CP
,
Guenzl
PM
,
Gisslinger
H
,
Gisslinger
B
,
Cleary
C
,
Kralovics
R
, et al. .
Long non-coding RNAs display higher natural expression variation than protein-coding genes in healthy humans
.
Genome Biol
2016
,
17
:
14
.

11

Qiao
J
,
Yao
H
,
Xia
Y
,
Chu
P
,
Li
M
,
Wu
Y
,
Li
W
, et al. .
Long non-coding RNAs expression profiles in hepatocytes of mice after hematopoietic stem cell transplantation
.
Iubmb Life
2016
,
68
:
232
241
.

12

Zhang
Q
,
Ge
H
,
Jiang
Y
,
Cheng
B
,
Zhou
D
,
Xu
N
.
Microarray profiling analysis of long non-coding RNAs expression in tendinopathy: identification for potential biomarkers and mechanisms
.
Int J Exp Pathol
2015
,
96
:
387
394
.

13

Xiong
G
,
Yang
L
,
Chen
Y
,
Fan
Z
.
Linc-POU3F3 promotes cell proliferation in gastric cancer via increasing T-reg distribution
.
Am J Transl Res
2015
,
7
:
2262
2269
.

14

Liao
Q
,
Liu
C
,
Yuan
X
,
Kang
S
,
Miao
R
,
Xiao
H
,
Zhao
G
, et al. .
Large-scale prediction of long non-coding RNA functions in a coding-non-coding gene co-expression network
.
Nucleic Acids Res
2011
,
39
:
3864
3878
.

15

Petri
A
,
Dybkaer
K
,
Bogsted
M
,
Thrue
CA
,
Hagedorn
PH
,
Schmitz
A
,
Bodker
JS
, et al. .
Long noncoding RNA expression during human B-cell development
.
PLoS One
2015
,
10
:
e138236
.

16

Aune
TM
,
Spurlock
CR
.
Long non-coding RNAs in innate and adaptive immunity
.
Virus Res
2016
,
212
:
146
160
.

17

Benveniste
MF
,
Welsh
J
,
Godoy
MC
,
Betancourt
SL
,
Mawlawi
OR
,
Munden
RF
.
New era of radiotherapy: an update in radiation-induced lung disease
.
Clin Radiol
2013
,
68
:
e275
e290
.

18

Allen
CP
,
Tinganelli
W
,
Sharma
N
,
Nie
J
,
Sicard
C
,
Natale
F
,
King
MR
, et al. .
DNA damage response proteins and oxygen modulate prostaglandin E2 growth factor release in response to low and high LET ionizing radiation
.
Front Oncol
2015
,
5
:
260
.

19

Maier
I
,
Schiestl
RH
.
Evidence from animal models: is a restricted or conventional intestinal microbiota composition predisposing to risk for high-LET radiation injury
.
Radiat Res
2015
,
183
:
589
593
.

20

Aghevlian
S
,
Boyle
AJ
,
Reilly
RM
.
Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting alpha-particles or Auger electrons
.
Adv Drug Deliv Rev
2015
.

21

Roy
S
,
Mondal
D
,
Melgandi
W
,
Jana
M
,
Chowdhury
KK
,
Das
S
,
Haresh
KP
, et al. .
Impact of post-operative radiation on coronary arteries in patients of early breast cancer: a pilot dosimetric study from a tertiary cancer care center from India
.
Indian J Cancer
2015
,
52
:
114
117
.

22

Jaffray
DA
,
Gospodarowicz
MK
.
Radiation therapy for cancer
.
2015
, 3: 34–39.

23

Ronjom
MF
.
Radiation-induced hypothyroidism after treatment of head and neck cancer
.
Dan Med J
2016
,
63
.

24

Liu
SZ
.
Nonlinear dose-response relationship in the immune system following exposure to ionizing radiation: mechanisms and implications
.
Nonlinearity Biol Toxicol Med
2003
,
1
:
71
92
.

25

Liu
SZ
.
Radiation-induced change in lymphocyte proliferation and its neuroendocrine regulation: dose-response relationship and pathophysiological implications
.
Nonlinearity Biol Toxicol Med
2004
,
2
:
233
243
.

26

Yang
N
,
Chaudhry
MA
,
Wallace
SS
.
Base excision repair by hNTH1 and hOGG1: a two edged sword in the processing of DNA damage in gamma-irradiated human cells
.
DNA Repair (Amst)
2006
,
5
:
43
51
.

27

Carante
MP
,
Altieri
S
,
Bortolussi
S
,
Postuma
I
,
Protti
N
,
Ballarini
F
.
Modeling radiation-induced cell death: role of different levels of DNA damage clustering
.
Radait Environ Biophys
2015
,
54
:
305
316
.

28

Huber
SM
,
Butz
L
,
Stegen
B
,
Klumpp
L
,
Klumpp
D
,
Eckert
F
.
Role of ion channels in ionizing radiation-induced cell death
.
Biochim Biophys Acta
2015
,
1848
:
2657
2664
.

29

Concannon
CG
,
Tuffy
LP
,
Weisova
P
,
Bonner
HP
,
Davila
D
,
Bonner
C
,
Devocelle
MC
, et al. .
AMP kinase-mediated activation of the BH3-only protein Bim couples energy depletion to stress-induced apoptosis
.
J Cell Biol
2010
,
189
:
83
94
.

30

Kilbride
SM
,
Farrelly
AM
,
Bonner
C
,
Ward
MW
,
Nyhan
KC
,
Concannon
CG
,
Wollheim
CB
, et al. .
AMP-activated protein kinase mediates apoptosis in response to bioenergetic stress through activation of the pro-apoptotic Bcl-2 homology domain-3-only protein BMF
.
J Biol Chem
2010
,
285
:
36199
36206
.

31

Maleszewska
M
,
Gjaltema
RA
,
Krenning
G
,
Harmsen
MC
.
Enhancer of zeste homolog-2 (EZH2) methyltransferase regulates transgelin/smooth muscle-22alpha expression in endothelial cells in response to interleukin-1beta and transforming growth factor-beta2
.
Cell Signal
2015
,
27
:
1589
1596
.

32

Dong
JC
,
Cheng
GH
,
Shan
YX
,
Wu
N
,
Shao
ML
,
Li
PW
,
Jin
SZ
.
Role of PLC-PIP2 and cAMP-PKA signal pathways in radiation-induced immune-suppressing effect
.
Biomed Environ Sci
2014
,
27
:
27
34
.

33

Dimitrova
N
,
Zamudio
JR
,
Jong
RM
,
Soukup
D
,
Resnick
R
,
Sarma
K
,
Ward
AJ
, et al. .
LincRNA-p21 activates p21 in cis to promote Polycomb target gene expression and to enforce the G1/S checkpoint
.
Mol Cell
2014
,
54
:
777
790
.

34

Liu
Q
,
Huang
J
,
Zhou
N
,
Zhang
Z
,
Zhang
A
,
Lu
Z
,
Wu
F
, et al. .
LncRNA loc285194 is a p53-regulated tumor suppressor
.
Nucleic Acids Res
2013
,
41
:
4976
4987
.

35

Hung
T
,
Wang
Y
,
Lin
MF
,
Koegel
AK
,
Kotake
Y
,
Grant
GD
,
Horlings
HM
, et al. .
Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters
.
Nat Genet
2011
,
43
:
621
629
.

36

Kurokawa
R
.
Promoter-associated long noncoding RNAs repress transcription through a RNA binding protein TLS
.
Adv Exp Med Biol
2011
,
722
:
196
208
.

37

Abbas
T
,
Dutta
A
.
p21 in cancer: intricate networks and multiple activities
.
Nat Rev Cancer
2009
,
9
:
400
414
.

38

Warfel
NA
,
El-Deiry
WS
.
p21WAF1 and tumourigenesis: 20 years after
.
Curr Opin Oncol
2013
,
25
:
52
58
.

Author notes

These authors contributed equally to this work.